Friedrich M, Villena-Heinsen C, Schweizer J, Holländer M, Stieber M, Schmidt W
Department of Gynecology and Obstetrics, University of Homburg/Saar, Deutschland.
Eur J Gynaecol Oncol. 1998;19(2):138-43.
With an incidence of 0.1% to 1.0% of all genital malignancies, primary tubal carcinoma is a rare malignant disease of the female genital tract. The prognosis is generally regarded as very poor. It is comparable with that of ovarian carcinoma. From 1980-1995, four patients were treated for primary tubal carcinoma at the Department of Gynecology and Obstetrics at the University of Homburg/Saar. FIGO stages IIa-IV were manifested as the primary stage. Surgery was performed as primary treatment in all patients. Both chemotherapy and percutaneous radiation were used as adjuvant postoperative therapy. The recurrence-free interval was 18-30 months. One patient died 21 months after primary diagnosis. The other free patients are in a period of follow-up observation of 16-96 months in an NC or CR status.
原发性输卵管癌占所有女性生殖系统恶性肿瘤的0.1%至1.0%,是一种罕见的女性生殖道恶性疾病。其预后通常被认为非常差,与卵巢癌相当。1980年至1995年期间,洪堡/萨尔大学妇产科有4例原发性输卵管癌患者接受了治疗。FIGO分期IIa-IV期为主要分期。所有患者均以手术作为主要治疗手段。化疗和经皮放疗均作为术后辅助治疗。无复发生存期为18至30个月。1例患者在初次诊断后21个月死亡。其他存活患者处于随访观察期,时间为16至96个月,状态为NC或CR。